Literature DB >> 19339146

Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients.

Mélina Fatséas1, Estelle Lavie, Cécile Denis, Marc Auriacombe.   

Abstract

Clinical observations have shown a high prevalence of benzodiazepine use among opiate-dependent patients. Our objective was to identify if distinct patterns of behavior could be associated with three different self-perceived motivations for benzodiazepine use: (a) exclusive self-therapeutic motivation, (b) exclusive hedonic motivation, and (c) combined self-therapeutic and hedonic motivation. Data were collected through a self-administered questionnaire in 92 opiate users in treatment in France (Aquitaine). The behaviors associated with exclusive self-therapeutic motivation included the search for an anxiolytic effect, oral administration, use within the context of a medical prescription, and use without other substances. The behaviors associated with exclusive hedonic motivation were use in combination with other substances, the obtaining of benzodiazepines by the black market, and use of other routes of administration in search of a "blackout." Among patients who reported both motivations, there were distinct trends of behavior according to motivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339146     DOI: 10.1016/j.jsat.2009.03.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  17 in total

1.  Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.

Authors:  Michael D Stein; Mitika Kanabar; Bradley J Anderson; Anna Lembke; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2016-06-16

2.  Motivations for prescription drug misuse among young men who have sex with men (YMSM) in Philadelphia.

Authors:  Aleksandar Kecojevic; Heather L Corliss; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2015-04-07

Review 3.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

4.  History of regular nonmedical sedative and/or alcohol use differentiates substance-use patterns and consequences among chronic heroin users.

Authors:  Tabitha E H Moses; Mark K Greenwald
Journal:  Addict Behav       Date:  2019-05-16       Impact factor: 3.913

5.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

6.  Posttraumatic Stress Symptoms and their Relationship to Drug and Alcohol use in an International Sample of Latino Immigrants.

Authors:  Zorangelí Ramos; Lisa R Fortuna; Michelle V Porche; Ye Wang; Patrick E Shrout; Stephen Loder; Samantha McPeck; Nestor Noyola; Manuela Toro; Rodrigo Carmona; Margarita Alegría
Journal:  J Immigr Minor Health       Date:  2017-06

7.  Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.

Authors:  Michael D Stein; Bradley J Anderson; Shannon R Kenney; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2017-03-09

8.  Heavy use versus less heavy use of sedatives among non-medical sedative users: Characteristics and correlates.

Authors:  Prasanthi Nattala; Kit Sang Leung; Arbi Ben Abdallah; Linda B Cottler
Journal:  Addict Behav       Date:  2010-09-25       Impact factor: 3.913

9.  Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.

Authors:  R Kathryn McHugh; Victoria R Votaw; Olivera Bogunovic; Sterling L Karakula; Margaret L Griffin; Roger D Weiss
Journal:  Addict Behav       Date:  2016-08-18       Impact factor: 3.913

10.  Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast.

Authors:  Pablo K Valente; Angela R Bazzi; Ellen Childs; Peter Salhaney; Joel Earlywine; Jennifer Olson; Dea L Biancarelli; Brandon D L Marshall; Katie B Biello
Journal:  Int J Drug Policy       Date:  2020-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.